The effect of different dosages of Methylprednisolone on platelet function and fibrinolysis system in cardiopulmonary bypass patients

Phase 2

• Conditions: Condition 1: Ischeamic heart diseases. Condition 2: Coagulation defects.; Atherosclerotic heart disease; Coagulation defects, unspecified

• Registration Number: IRCT201010233438N2
• Lead Sponsor: Iran Blood Transfusion Organization(IBTO)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

1- Patients with coronary artery disease undergoing elective surgery 2- Both male and female patients are eligible 3- between 50 and 70 years old 4- Not having a aspirin 5 days prior to surgery 5- Not using heparin and any other steroid

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood loss. Timepoint: 24 hour after operation. Method of measurement: Scaled buttel tube.;Blood product requirements. Timepoint: At operation and ICU room. Method of measurement: The number of bags.